February 2026 UPMC for You and UPMC Community HealthChoices formulary update

Feb. 2026Pharmacy Updates

Pulmicort Flexhaler has a new distributor, Rubicon Holding. National Drug Codes (NDCs) for Pulmicort Flexhaler from Rubicon Holding are not included in the Medicaid Drug Rebate program and are not covered under the Medicaid Prescription Drug Program. Pulmicort Flexhaler NDCs from the previous manufacturer, H2 Pharma, have been discontinued but may be billed/dispensed until supplies are exhausted. 

To avoid denials at the pharmacy, prescribers are encouraged to begin transitioning current Pulmicort Flexhaler patients to covered alternatives as soon as possible.

Preferred/Covered PDL alternatives for Pulmicort Flexhaler include the following*:

  • Arnuity Ellipta
  • Asmanex HFA
  • Asmanex Twisthaler
  • Budesonide 0.25 mg/2 mL and 0.5 mg/2 mL Respules
  • Qvar Redihaler
  • Fluticasone Propionate HFA for patients < 19 years old

*The DHS PDL is subject to review and may be revised periodically.

Recent Announcements

PA DOH Antibiotic Stewardship Resources

Order antibiotic stewardship resources at no cost
Jun. 2026Important Notices

Medical device correction: Omnipod (Insulet – May 2026)

Insulet Corporation Inc. has announced a medical device correction for certain Omnipod Pods. These pods are wearable devices that are used to deliver insulin.
Jun. 2026Pharmacy Updates

Clinical documentation required for medical policy prior authorizations

As you know, UPMC Health Plan requires certain clinical documentation/notes in support of a request for prior authorization for the listed procedures below in accordance with its established policies and procedures, in addition to CMS requirements that medical record documentation must support the medical necessity of the services requested.
Jun. 2026Important Notices